Kotaro Iijima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kotaro Iijima has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Naoya Murakami
Department of Radiation Oncology, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421
8 shared publications - Hiroyuki Okamoto
Section of Radiation Safety and Quality Assurance, National Cancer Center Hospital , 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045
7 shared publications Hiroki Nakayama
Section of Radiation Safety and Quality Assurance, National Cancer Center Hospital , 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045
6 shared publicationsSatoshi Nakamura
Section of Radiation Safety and Quality Assurance, National Cancer Center Hospital , 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045
6 shared publicationsHiroshi Igaki
Department of Radiation Oncology, National Cancer Center Hospital , 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
5 shared publications- Jun Takatsu
Department of Radiation Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan
5 shared publications
Latest Publications
- 25 July 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1187) , 2345-2355
Dosimetric robustness of tumor- and fiducial-based tracking in Radixact lung stereotactic body radiotherapy: a 4-dimensional CT-based simulation using imaging-derived tracking-error scenarios
Objectives: To compare the dosimetry and robustness of 2 Radixact Synchrony lung stereotactic body radiotherapy (SBRT) tracking strategies: tumor-based lung tracking with respiratory modelling (LwR) and fiducial-based tracking with respiratory modelling (FwR). Methods: Ten stage I non-small-cell lung cancer patients were retrospectively analyzed. SBRT plans (42 Gy in 4 fractions) were generated on maximum-exhalation computed tomography (CT) using planning target volumes (PTVs) created by 3-7 mm isotropic gross tumor volume (GTV) expansion. Each plan was mapped to all 4-dimensional CT (4DCT) phases via isocenter shifts from phase-specific GTV (LwR) or individual fiducial displacement (FwR). Deformable dose accumulation yielded LwR, nearest FwR, and farthest FwR simulated plans. GTV/PTV V100%, representative organ-at-risk (OAR) doses, and robustness versus target localization error, tumor-fiducial distance, and tumor volume were evaluated. Results: With a 3-mm PTV margin, FwR showed larger losses in GTV coverage and PTV robustness than LwR (maximum decreases of 9.0% and 26.0%). FwR was less robust, particularly with unfavorable tumor-fiducial geometry. Larger PTV margins progressively mitigated FwR coverage degradation while maintaining acceptable OAR doses. Conclusions: For lung SBRT delivered with Radixact Synchrony, LwR was more robust than FwR in this cohort, for which all tumor-fiducial distances exceeded 20 mm. When FwR is required, particularly under suboptimal tumor-fiducial geometry, a 3-mm margin should be used cautiously, and patient-specific evaluation of 5-7 mm margins within OAR dose constraints may be necessary. Advances in knowledge: A 4DCT-based simulation using imaging-derived tracking-error scenarios reveals dosimetric robustness differences between LwR and FwR tracking.
- 25 July 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1187) , 2345-2355
Dosimetric robustness of tumor- and fiducial-based tracking in Radixact lung stereotactic body radiotherapy: a 4-dimensional CT-based simulation using imaging-derived tracking-error scenarios
Objectives: To compare the dosimetry and robustness of 2 Radixact Synchrony lung stereotactic body radiotherapy (SBRT) tracking strategies: tumor-based lung tracking with respiratory modelling (LwR) and fiducial-based tracking with respiratory modelling (FwR). Methods: Ten stage I non-small-cell lung cancer patients were retrospectively analyzed. SBRT plans (42 Gy in 4 fractions) were generated on maximum-exhalation computed tomography (CT) using planning target volumes (PTVs) created by 3-7 mm isotropic gross tumor volume (GTV) expansion. Each plan was mapped to all 4-dimensional CT (4DCT) phases via isocenter shifts from phase-specific GTV (LwR) or individual fiducial displacement (FwR). Deformable dose accumulation yielded LwR, nearest FwR, and farthest FwR simulated plans. GTV/PTV V100%, representative organ-at-risk (OAR) doses, and robustness versus target localization error, tumor-fiducial distance, and tumor volume were evaluated. Results: With a 3-mm PTV margin, FwR showed larger losses in GTV coverage and PTV robustness than LwR (maximum decreases of 9.0% and 26.0%). FwR was less robust, particularly with unfavorable tumor-fiducial geometry. Larger PTV margins progressively mitigated FwR coverage degradation while maintaining acceptable OAR doses. Conclusions: For lung SBRT delivered with Radixact Synchrony, LwR was more robust than FwR in this cohort, for which all tumor-fiducial distances exceeded 20 mm. When FwR is required, particularly under suboptimal tumor-fiducial geometry, a 3-mm margin should be used cautiously, and patient-specific evaluation of 5-7 mm margins within OAR dose constraints may be necessary. Advances in knowledge: A 4DCT-based simulation using imaging-derived tracking-error scenarios reveals dosimetric robustness differences between LwR and FwR tracking.
- Open Access
- 7 June 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (6) , e70620
Development of a virtual phantom for HDR cervical cancer brachytherapy: A multi‐institutional tool for training, quality assurance, and variability reduction
Background: High‐dose‐rate brachytherapy (HDR‐BT) is a critical modality in the treatment of cervical cancer, requiring accurate and efficient treatment planning. Unlike external beam radiation therapy, HDR‐BT demands specialized skills and training. However, accessible and standardized educational tools—particularly virtual phantoms—remain limited. Purpose: This study aimed to develop a virtual phantom tailored for HDR‐BT treatment planning in cervical cancer management. The objective was to support planner training, reduce interobserver error, and provide a scalable platform for quality assurance and educational use. Methods: Four virtual phantoms (VP1–VP4) were generated using computed tomography images of physical models equipped with different applicators (Fletcher, Geneva, VCMC, and Venezia). Dose constraints were initially established through a single‐institutional planning study (SIPS) and validated via a multi‐institutional planning study involving seven institutions. Dose–volume parameters (DVPs) were analyzed to assess compliance with the constraints and to quantify inter‐planner error (IPE) and inter‐institutional error (IIE). The coefficient of variation (CV) and F‐tests were employed to evaluate variability. Results: Initial compliance with SIPS‐defined dose constraints ranged from 35.4% to 70.8%. As compliance was low across all phantoms, we adjusted the spatial relationships between the target volume and organs at risk. The compliance then improved to 83.3%‐100.0%. IIE was greater than IPE, with several DVPs exhibiting CVs above 20%. The hyper‐dose sleeve (V200%) demonstrated the highest variability, with CVs exceeding 40% in some cases. These findings emphasize the importance of standardized training tools for reducing interobserver variability. Conclusions: The developed virtual phantoms offer practical and accessible tools for HDR‐BT treatment planning education. Its digital format enables broad dissemination and adaptability across institutions, supporting both training and clinical use. Ongoing refinement will be necessary to ensure continued relevance in evolving clinical environments and contribution to consistent, high‐quality care in gynecologic brachytherapy.
- 7 June 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (6) , e70620
Open AccessDevelopment of a virtual phantom for HDR cervical cancer brachytherapy: A multi‐institutional tool for training, quality assurance, and variability reduction
Background: High‐dose‐rate brachytherapy (HDR‐BT) is a critical modality in the treatment of cervical cancer, requiring accurate and efficient treatment planning. Unlike external beam radiation therapy, HDR‐BT demands specialized skills and training. However, accessible and standardized educational tools—particularly virtual phantoms—remain limited. Purpose: This study aimed to develop a virtual phantom tailored for HDR‐BT treatment planning in cervical cancer management. The objective was to support planner training, reduce interobserver error, and provide a scalable platform for quality assurance and educational use. Methods: Four virtual phantoms (VP1–VP4) were generated using computed tomography images of physical models equipped with different applicators (Fletcher, Geneva, VCMC, and Venezia). Dose constraints were initially established through a single‐institutional planning study (SIPS) and validated via a multi‐institutional planning study involving seven institutions. Dose–volume parameters (DVPs) were analyzed to assess compliance with the constraints and to quantify inter‐planner error (IPE) and inter‐institutional error (IIE). The coefficient of variation (CV) and F‐tests were employed to evaluate variability. Results: Initial compliance with SIPS‐defined dose constraints ranged from 35.4% to 70.8%. As compliance was low across all phantoms, we adjusted the spatial relationships between the target volume and organs at risk. The compliance then improved to 83.3%‐100.0%. IIE was greater than IPE, with several DVPs exhibiting CVs above 20%. The hyper‐dose sleeve (V200%) demonstrated the highest variability, with CVs exceeding 40% in some cases. These findings emphasize the importance of standardized training tools for reducing interobserver variability. Conclusions: The developed virtual phantoms offer practical and accessible tools for HDR‐BT treatment planning education. Its digital format enables broad dissemination and adaptability across institutions, supporting both training and clinical use. Ongoing refinement will be necessary to ensure continued relevance in evolving clinical environments and contribution to consistent, high‐quality care in gynecologic brachytherapy.
- 20 January 2026
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 19 (1) , 284-292
Impact of the locking function of hybrid inverse planning optimization on the treatment plan quality of intracavitary/interstitial brachytherapy for locally advanced cervical cancer
Purpose: To investigate the dosimetric characteristics of intracavitary/interstitial brachytherapy (IC/ISBT) plans created via the hybrid inverse planning optimization (HIPO) algorithm with the dwell time Lock function. Materials and methods: Sixteen patients with locally advanced cervical cancer treated with high-dose-rate IC/ISBT were evaluated. Based on the clinical plan data, five plans were retrospectively created: Manchester-based HIPO for needles, HIPO for all applicators, HIPO for needles after HIPO for tandem/ovoid, HIPO for ovoid after HIPO for tandem/needle, and HIPO for ovoid/needle after HIPO for tandem. The target coverage, organs at risk (OARs) doses, therapeutic ratios, and the dwell time contributions of the needles were analyzed to evaluate the plan quality. Dice similarity coefficients (DSCs) between clinical plan and each created plan were calculated to evaluate the similarity of the shape of the dose distribution. Results: All plans created using HIPO had a sufficient target coverage, while the OAR dose for the Manchester-based HIPO plans was considerably higher than the other plans. The plan with HIPO for all applicators and with HIPO for the ovoid applicator after HIPO for tandem/needles had comparable or superior therapeutic ratios than those of the clinical plan while the dwell time contributions of the needle were much larger. For DSCs, an intermediate to low correlation was observed between the clinical plan and all HIPO plans. Conclusions: The HIPO algorithm could create high-quality IC/ISBT plans, although the dosimetric consequences were affected by the locking function.
- 20 January 2026
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 19 (1) , 284-292
Impact of the locking function of hybrid inverse planning optimization on the treatment plan quality of intracavitary/interstitial brachytherapy for locally advanced cervical cancer
Purpose: To investigate the dosimetric characteristics of intracavitary/interstitial brachytherapy (IC/ISBT) plans created via the hybrid inverse planning optimization (HIPO) algorithm with the dwell time Lock function. Materials and methods: Sixteen patients with locally advanced cervical cancer treated with high-dose-rate IC/ISBT were evaluated. Based on the clinical plan data, five plans were retrospectively created: Manchester-based HIPO for needles, HIPO for all applicators, HIPO for needles after HIPO for tandem/ovoid, HIPO for ovoid after HIPO for tandem/needle, and HIPO for ovoid/needle after HIPO for tandem. The target coverage, organs at risk (OARs) doses, therapeutic ratios, and the dwell time contributions of the needles were analyzed to evaluate the plan quality. Dice similarity coefficients (DSCs) between clinical plan and each created plan were calculated to evaluate the similarity of the shape of the dose distribution. Results: All plans created using HIPO had a sufficient target coverage, while the OAR dose for the Manchester-based HIPO plans was considerably higher than the other plans. The plan with HIPO for all applicators and with HIPO for the ovoid applicator after HIPO for tandem/needles had comparable or superior therapeutic ratios than those of the clinical plan while the dwell time contributions of the needle were much larger. For DSCs, an intermediate to low correlation was observed between the clinical plan and all HIPO plans. Conclusions: The HIPO algorithm could create high-quality IC/ISBT plans, although the dosimetric consequences were affected by the locking function.
- Open Access
- 13 January 2026
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 67 (1) , 20-28
Cherenkov emission–based quality assurance for linear accelerators
When electrons exceed the speed of light in a medium, they emit low-intensity visible light, known as Cherenkov emission (CE). This study proposes a novel CE-based quality assurance (QA) test for linear accelerators. A CE-based QA (C-QA) phantom incorporating a mock tumor and four CE observation plates (top, bottom, left, and right) was developed. After tumor-based alignment using cone-beam computed tomography (CBCT), lateral and posterior fields were used for irradiation. A C-Dose camera was employed to measure the treatment position, gantry angle, photon energy (TPR20,10), and CE counts for both fields. The treatment position and TPR20,10 were determined by analyzing the changes in the CE profile, while the gantry angle was calculated based on the tilt between the entry and exit field positions. Confidence limits were evaluated over a three-month period, during which long-term testing demonstrated favorable results. The standard deviations (σ) for CBCT-based positional accuracy and gantry angle were within ±1 mm in all three directions and within 1°, respectively. The mean ± σ for TPR20,10 was 0.631 ± 0.004, closely matching the 0.629 measured using an ionization chamber. Detected CE counts exhibited a higher variation (σ = 2.7%). CE-based QA appears to be an effective and reliable method for radiotherapy. Treatment position could be directly measured without conventional dosimetric devices, while CE imaging simultaneously evaluated positional accuracy, gantry angle, and photon energy (TPR20,10). However, accurate assessment of linear accelerator dose output remains a challenge, and the quantification of CE counts requires further investigation.
- 13 January 2026
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 67 (1) , 20-28
Open AccessCherenkov emission–based quality assurance for linear accelerators
When electrons exceed the speed of light in a medium, they emit low-intensity visible light, known as Cherenkov emission (CE). This study proposes a novel CE-based quality assurance (QA) test for linear accelerators. A CE-based QA (C-QA) phantom incorporating a mock tumor and four CE observation plates (top, bottom, left, and right) was developed. After tumor-based alignment using cone-beam computed tomography (CBCT), lateral and posterior fields were used for irradiation. A C-Dose camera was employed to measure the treatment position, gantry angle, photon energy (TPR20,10), and CE counts for both fields. The treatment position and TPR20,10 were determined by analyzing the changes in the CE profile, while the gantry angle was calculated based on the tilt between the entry and exit field positions. Confidence limits were evaluated over a three-month period, during which long-term testing demonstrated favorable results. The standard deviations (σ) for CBCT-based positional accuracy and gantry angle were within ±1 mm in all three directions and within 1°, respectively. The mean ± σ for TPR20,10 was 0.631 ± 0.004, closely matching the 0.629 measured using an ionization chamber. Detected CE counts exhibited a higher variation (σ = 2.7%). CE-based QA appears to be an effective and reliable method for radiotherapy. Treatment position could be directly measured without conventional dosimetric devices, while CE imaging simultaneously evaluated positional accuracy, gantry angle, and photon energy (TPR20,10). However, accurate assessment of linear accelerator dose output remains a challenge, and the quantification of CE counts requires further investigation.
- Open Access
- 5 December 2025
- Published by Oxford University Press (OUP) in BJR|case reports
- Vol. 12 (1)
Local control of locally advanced uterine sarcoma achieved by cervical brachytherapy with gel spacer following cyclic hypofractionated radiation therapy (QUAD shot) in a patient who refused surgery
Radiation therapy is not mentioned in various guidelines for primary treatment of uterine sarcoma. Radiation therapy is considered useful for palliative purposes, but an optimal radiation schedule has not been established. An 85-year-old woman was recommended to undergo surgery for locally advanced uterine sarcoma of unknown histological subtype, but she refused because of her poor physical and social circumstances. She instead received chemotherapy; however, the lesion progressed, and the patient opted for best supportive care. Palliative radiation therapy was indicated for genital bleeding. She thereafter received the QUAD shot regimen, in which 3.7 Gy was administered twice a day for 2 consecutive days and repeated every 4 weeks for a total dose of 44.4 Gy in 3 cycles. The lesion significantly decreased in size, and no new regional or distant metastases were identified. Although only palliative radiation therapy was initially intended, the favourable response with no new lesion development prompted us to offer additional brachytherapy for curative intent, and the patient accepted. She underwent 2 sessions of uterine cervical intracavitary and interstitial brachytherapy using a gel spacer, and local control of the lesion was achieved at 1-year and 3 months follow-up of treatment without major adverse events. In select patients for whom a favourable response is achieved after the QUAD shot, the addition of intracavitary and interstitial brachytherapy with a gel spacer may result in curative treatment. This therapy could be a very promising and attractive option for patients with uterine sarcoma who have complications or special social circumstances.
- 5 December 2025
- Published by Oxford University Press (OUP) in BJR|case reports
- Vol. 12 (1)
Open AccessLocal control of locally advanced uterine sarcoma achieved by cervical brachytherapy with gel spacer following cyclic hypofractionated radiation therapy (QUAD shot) in a patient who refused surgery
Radiation therapy is not mentioned in various guidelines for primary treatment of uterine sarcoma. Radiation therapy is considered useful for palliative purposes, but an optimal radiation schedule has not been established. An 85-year-old woman was recommended to undergo surgery for locally advanced uterine sarcoma of unknown histological subtype, but she refused because of her poor physical and social circumstances. She instead received chemotherapy; however, the lesion progressed, and the patient opted for best supportive care. Palliative radiation therapy was indicated for genital bleeding. She thereafter received the QUAD shot regimen, in which 3.7 Gy was administered twice a day for 2 consecutive days and repeated every 4 weeks for a total dose of 44.4 Gy in 3 cycles. The lesion significantly decreased in size, and no new regional or distant metastases were identified. Although only palliative radiation therapy was initially intended, the favourable response with no new lesion development prompted us to offer additional brachytherapy for curative intent, and the patient accepted. She underwent 2 sessions of uterine cervical intracavitary and interstitial brachytherapy using a gel spacer, and local control of the lesion was achieved at 1-year and 3 months follow-up of treatment without major adverse events. In select patients for whom a favourable response is achieved after the QUAD shot, the addition of intracavitary and interstitial brachytherapy with a gel spacer may result in curative treatment. This therapy could be a very promising and attractive option for patients with uterine sarcoma who have complications or special social circumstances.
- 13 November 2025
- Published by Elsevier in Brachytherapy
- Vol. 25 (1) , 145-153
Multicenter study on mechanical accuracy of short dwell time and source transit for HDR Ir-192 brachytherapy treatment machine
- 13 November 2025
- Published by Elsevier in Brachytherapy
- Vol. 25 (1) , 145-153
Multicenter study on mechanical accuracy of short dwell time and source transit for HDR Ir-192 brachytherapy treatment machine
- Open Access
- 9 September 2024
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 65 (5) , 603-618
Analysis of human errors in the operation of various treatment planning systems over a 10-year period
The present study aimed to summarize and report data on errors related to treatment planning, which were collected by medical physicists. The following analyses were performed based on the 10-year error report data: (1) listing of high-risk errors that occurred and (2) the relationship between the number of treatments and error rates, (3) usefulness of the Automated Plan Checking System (APCS) with the Eclipse Scripting Application Programming Interface and (4) the relationship between human factors and error rates. Differences in error rates were observed before and after the use of APCS. APCS reduced the error rate by ~1% for high-risk errors and 3% for low-risk errors. The number of treatments was negatively correlated with error rates. Therefore, we examined the relationship between the workload of medical physicists and error occurrence and revealed that a very large workload may contribute to overlooking errors. Meanwhile, an increase in the number of medical physicists may lead to the detection of more errors. The number of errors was correlated with the number of physicians with less clinical experience; the error rates were higher when there were more physicians with less experience. This is likely due to the lack of training among clinically inexperienced physicians. An environment to provide adequate training is important, as inexperience in clinical practice can easily and directly lead to the occurrence of errors. In any environment, the need for additional plan checkers is an essential factor for eliminating errors.
- 9 September 2024
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 65 (5) , 603-618
Open AccessAnalysis of human errors in the operation of various treatment planning systems over a 10-year period
The present study aimed to summarize and report data on errors related to treatment planning, which were collected by medical physicists. The following analyses were performed based on the 10-year error report data: (1) listing of high-risk errors that occurred and (2) the relationship between the number of treatments and error rates, (3) usefulness of the Automated Plan Checking System (APCS) with the Eclipse Scripting Application Programming Interface and (4) the relationship between human factors and error rates. Differences in error rates were observed before and after the use of APCS. APCS reduced the error rate by ~1% for high-risk errors and 3% for low-risk errors. The number of treatments was negatively correlated with error rates. Therefore, we examined the relationship between the workload of medical physicists and error occurrence and revealed that a very large workload may contribute to overlooking errors. Meanwhile, an increase in the number of medical physicists may lead to the detection of more errors. The number of errors was correlated with the number of physicians with less clinical experience; the error rates were higher when there were more physicians with less experience. This is likely due to the lack of training among clinically inexperienced physicians. An environment to provide adequate training is important, as inexperience in clinical practice can easily and directly lead to the occurrence of errors. In any environment, the need for additional plan checkers is an essential factor for eliminating errors.
- Open Access
Dose Contribution to the Regional Lymph-Node Metastases and Point B from Intracavity and Interstitial Hybrid Brachytherapy in Locally Advanced Cervical Cancer
Purpose: Analyzing dose distributions to regional lymph-node metastases (RLNMs) in locally advanced cervical cancer (LACC) patients undergoing intracavitary and interstitial hybrid brachytherapy (IC/IS). Methods: Dose distributions of eleven LACC patients with 38 RLNMs, and who received 38 IC/IS sessions were analyzed in EQD2, considering RLNM positions and ipsilateral interstitial needles; these RLNMs, excepting the para-aortic region, were classified into four groups. Results: RLNMs had a median of two ipsilateral interstitial needles per session. Significant differences were observed in total RLNM D90, depending on whether the position was cranial or caudal of the uterine base (85.5 vs. 378.9 cGy, p < 0.0001), and whether the RLNM D90 was associated with a number of ipsilateral interstitial needles between 0–1 or 2 or more (68.4 vs. 112.2 cGy, p = 0.006) per session. At each session, Group 1 RLNMs (cranial of the uterine base, 0–1 ipsilateral interstitial needle) had a mean D90 of 21.1 cGy; Group 2 (cranial, 2 or more), 73.8; Group 3 (caudal, 0–1), 94.7; and Group 4 (caudal, 2 or more), 136.1. Conclusion: RLNMs located caudal of the uterine base associated with two or more ipsilateral interstitial needles in IC/IS had a higher dose contribution, which should be considered when calculating the RLNMs’ dose of external beam boost irradiation.
Open AccessDose Contribution to the Regional Lymph-Node Metastases and Point B from Intracavity and Interstitial Hybrid Brachytherapy in Locally Advanced Cervical Cancer
Purpose: Analyzing dose distributions to regional lymph-node metastases (RLNMs) in locally advanced cervical cancer (LACC) patients undergoing intracavitary and interstitial hybrid brachytherapy (IC/IS). Methods: Dose distributions of eleven LACC patients with 38 RLNMs, and who received 38 IC/IS sessions were analyzed in EQD2, considering RLNM positions and ipsilateral interstitial needles; these RLNMs, excepting the para-aortic region, were classified into four groups. Results: RLNMs had a median of two ipsilateral interstitial needles per session. Significant differences were observed in total RLNM D90, depending on whether the position was cranial or caudal of the uterine base (85.5 vs. 378.9 cGy, p < 0.0001), and whether the RLNM D90 was associated with a number of ipsilateral interstitial needles between 0–1 or 2 or more (68.4 vs. 112.2 cGy, p = 0.006) per session. At each session, Group 1 RLNMs (cranial of the uterine base, 0–1 ipsilateral interstitial needle) had a mean D90 of 21.1 cGy; Group 2 (cranial, 2 or more), 73.8; Group 3 (caudal, 0–1), 94.7; and Group 4 (caudal, 2 or more), 136.1. Conclusion: RLNMs located caudal of the uterine base associated with two or more ipsilateral interstitial needles in IC/IS had a higher dose contribution, which should be considered when calculating the RLNMs’ dose of external beam boost irradiation.
- Open Access
- 18 February 2024
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 25 (5) , e14305
Dosimetric evaluation in Helical TomoTherapy for lung SBRT using Monte Carlo‐based independent dose verification software
Purpose: To elucidate the dosimetric errors caused by a model‐based algorithm in lung stereotactic body radiation therapy (SBRT) with Helical TomoTherapy (HT) using Monte Carlo (MC)‐based dose verification software.Methods: For 38 plans of lung SBRT, the dose calculation accuracy of a treatment planning system (TPS) of HT was compared with the results of DoseCHECK, the commercial MC‐based independent verification software. The following indices were extracted to evaluate the correlation of dosimetric errors: (1) target volume, (2) average computed tomography (CT) value of the planning target volume (PTV) margin, and (3) average CT value of surrounding 2‐mm area of the PTV (PTV ring). Receiver operating characteristic (ROC) analyses determined the threshold for 5% of differences in PTV D95%. Then, the 38 plans were classified into two groups using the cutoff values of ROC analysis for these three indices. Dosimetric differences between groups were statistically compared using the Mann–Whitney U test.Results: TPS of HT overestimated by more than 5% in the PTV D95% in 16 of 38 plans. The PTV ring showed the strongest correlation with dosimetric differences. The cutoff value for the target volume, the PTV margin, and the PTV ring was 14.7 cc, −754 HU, and −708 HU, respectively. The area under the curve (AUC) for the target volume, the PTV margin, and the PTV ring were 0.835, 0.878, and 0.932, respectively. Dosimetric errors more than 5% were observed when the PTV volume was less than 15 cc or when the CT value around the target was less than −700 HU.Conclusion: The TPS of HT might overestimate the PTV dose by more than 5% if any the three indices in this study were below threshold. Therefore, independent verification with an MC‐based algorithm should be strongly recommended for lung SBRT in HT.
- 18 February 2024
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 25 (5) , e14305
Open AccessDosimetric evaluation in Helical TomoTherapy for lung SBRT using Monte Carlo‐based independent dose verification software
Purpose: To elucidate the dosimetric errors caused by a model‐based algorithm in lung stereotactic body radiation therapy (SBRT) with Helical TomoTherapy (HT) using Monte Carlo (MC)‐based dose verification software.Methods: For 38 plans of lung SBRT, the dose calculation accuracy of a treatment planning system (TPS) of HT was compared with the results of DoseCHECK, the commercial MC‐based independent verification software. The following indices were extracted to evaluate the correlation of dosimetric errors: (1) target volume, (2) average computed tomography (CT) value of the planning target volume (PTV) margin, and (3) average CT value of surrounding 2‐mm area of the PTV (PTV ring). Receiver operating characteristic (ROC) analyses determined the threshold for 5% of differences in PTV D95%. Then, the 38 plans were classified into two groups using the cutoff values of ROC analysis for these three indices. Dosimetric differences between groups were statistically compared using the Mann–Whitney U test.Results: TPS of HT overestimated by more than 5% in the PTV D95% in 16 of 38 plans. The PTV ring showed the strongest correlation with dosimetric differences. The cutoff value for the target volume, the PTV margin, and the PTV ring was 14.7 cc, −754 HU, and −708 HU, respectively. The area under the curve (AUC) for the target volume, the PTV margin, and the PTV ring were 0.835, 0.878, and 0.932, respectively. Dosimetric errors more than 5% were observed when the PTV volume was less than 15 cc or when the CT value around the target was less than −700 HU.Conclusion: The TPS of HT might overestimate the PTV dose by more than 5% if any the three indices in this study were below threshold. Therefore, independent verification with an MC‐based algorithm should be strongly recommended for lung SBRT in HT.
- Open Access
- 1 January 2024
- Published by XMLink in Imaging Science in Dentistry
- Vol. 54 (2) , 129-137
A novel method for determining dose distribution on panoramic reconstruction computed tomography images from radiotherapy computed tomography
Okamoto H, et al. Imaging Sci Dent. 2024 Jun;54(2):129-137. https://doi.org/10.5624/isd.20230230
- 1 January 2024
- Published by XMLink in Imaging Science in Dentistry
- Vol. 54 (2) , 129-137
Open AccessA novel method for determining dose distribution on panoramic reconstruction computed tomography images from radiotherapy computed tomography
Okamoto H, et al. Imaging Sci Dent. 2024 Jun;54(2):129-137. https://doi.org/10.5624/isd.20230230